Interestingly, we previously noted that high expression of 5MP1, but not that of 5MP2, correlates with poorer prognosis of breast and lung cancer patients, while in contrast, high expression of eIF5 correlates with their better prognosis [31]. This evidence concerns the gene EIF5 and lung carcinoma.